Mission statement · Company scope
“Our mission is to design and deliver next generation immunotherapies for neurodegenerative and neuroinflammatory diseases.”
In use2026 – now1 sighting
First seenMay 2026Added
Last seenMay 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Product offering (primary) · Innovation
- Leads with
- Product
- Best for
- Climate & health
- Formula
- We make [product] for [who]
- Tone
- Plain
- Length
- 15 words · reading grade 21.7
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_42d547dafadb65a1
- Classification confidence
- 0.59
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-05-01 · sec_sentence · 20-F · accession 0001213900-26-051015
View filing ↗0 to compareCompare